Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia
Clinical trial NCT04349306 · COMPLETED
Trial details
- NCT number
- NCT04349306
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2021-03-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.